Molecular nutrition & food research · 2026
The Dietary Protein Source Modulates Obesity Development and Induces Distinct Plasma Lipid Profiles and Transcriptome Profiles in Liver and Adipose Tissue.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Myrmel Lene S, Fjære Even, Bernhard Annette, Rasinger Josef D, Nøstbakken Ole Jakob, Søiland Helene, Rausch Philipp, von Bergen Martin, Rolle-Kampzcyk Ulrike, Xiao Liang, Zhou Hanlin, Li Guibo, Kristiansen Karsten, Madsen Lise
Аннотация
Diets based on dairy or seafood proteins are reported to be less obesogenic than diets based on terrestrial meat proteins. The metabolic pathways underlying these differences, including processes related to thermogenesis, remain incompletely understood. Here, we investigated responses at levels of the transcriptome and the metabolome associated with potentially obesogenic high-fat, high-protein diets using casein, cod, or chicken as protein sources in mice kept at thermoneutral conditions or room temperature to evaluate metabolic responses to different housing temperatures. By performing plasma metabolomics analyses combined with RNA sequencing and gene set enrichment analyses of liver, muscle, white- and brown adipose tissue, we aimed to decipher the metabolic output and pathways modulated by intake of different dietary proteins. Dietary protein intake of casein, cod, or chicken led to differences in obesity development independent of housing temperature. The diet-specific phenotype was associated with a distinct plasma lipid profile and transcriptomic profile in liver and adipose tissue. One-carbon metabolism emerged as a potentially affected key pathway, and the mechanistic target of rapamycin complex 1/2 appeared as a predicted upstream regulator and accordingly suggested to be associated with protein source-dependent differences in obesity development and related metabolic disturbances.